Ondine Biomedical Inc. (LON:OBI – Get Free Report) shot up 26.8% during mid-day trading on Friday . The company traded as high as GBX 6.50 ($0.08) and last traded at GBX 6.50 ($0.08). 490,817 shares changed hands during mid-day trading, an increase of 89% from the average session volume of 259,447 shares. The stock had previously closed at GBX 5.13 ($0.06).
Ondine Biomedical Stock Up 28.8 %
The company has a market capitalization of £14.97 million, a price-to-earnings ratio of -110.00 and a beta of -0.15. The company has a quick ratio of 8.26, a current ratio of 2.34 and a debt-to-equity ratio of 24.39. The business has a 50-day moving average price of GBX 8.21 and a 200-day moving average price of GBX 9.23.
Ondine Biomedical Company Profile
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Read More
- Five stocks we like better than Ondine Biomedical
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- MarketBeat Week in Review – 4/29 – 5/3
- What is Insider Trading? What You Can Learn from Insider Trading
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
